Mitochondrial determinants of doxorubicin-induced cardiomyopathy KB Wallace, VA Sardão, PJ Oliveira Circulation research 126 (7), 926-941, 2020 | 370 | 2020 |
Mitochondria and reactive oxygen species in aging and age-related diseases C Giorgi, S Marchi, ICM Simoes, Z Ren, G Morciano, M Perrone, ... International review of cell and molecular biology 340, 209-344, 2018 | 269 | 2018 |
Reactivation of dihydroorotate dehydrogenase-driven pyrimidine biosynthesis restores tumor growth of respiration-deficient cancer cells M Bajzikova, J Kovarova, AR Coelho, S Boukalova, S Oh, K Rohlenova, ... Cell metabolism 29 (2), 399-416. e10, 2019 | 217 | 2019 |
Ketogenic diets: from cancer to mitochondrial diseases and beyond AF Branco, A Ferreira, RF Simões, S Magalhães‐Novais, C Zehowski, ... European journal of clinical investigation 46 (3), 285-298, 2016 | 188 | 2016 |
Phytoestrogens as alternative hormone replacement therapy in menopause: What is real, what is unknown AC Moreira, AM Silva, MS Santos, VA Sardao The Journal of steroid biochemistry and molecular biology 143, 61-71, 2014 | 172 | 2014 |
Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line TL Serafim, PJ Oliveira, VA Sardao, E Perkins, D Parke, J Holy Cancer Chemotherapy and Pharmacology 61, 1007-1018, 2008 | 166 | 2008 |
Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets VA Sardão, PJ Oliveira, J Holy, CR Oliveira, KB Wallace Cell biology and toxicology 25, 227-243, 2009 | 165 | 2009 |
Mitochondrially targeted effects of berberine [Natural Yellow 18, 5, 6-dihydro-9, 10-dimethoxybenzo (g)-1, 3-benzodioxolo (5, 6-a) quinolizinium] on K1735-M2 mouse melanoma … GC Pereira, AF Branco, JAC Matos, SL Pereira, D Parke, EL Perkins, ... Journal of pharmacology and experimental therapeutics 323 (2), 636-649, 2007 | 153 | 2007 |
Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats A Ascensão, J Lumini-Oliveira, NG Machado, RM Ferreira, IO Gonçalves, ... Clinical science 120 (1), 37-49, 2011 | 148 | 2011 |
Investigating drug-induced mitochondrial toxicity: a biosensor to increase drug safety? CV Pereira, AC Moreira, SP Pereira, NG Machado, FS Carvalho, ... Current drug safety 4 (1), 34-54, 2009 | 118 | 2009 |
Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts VA Sardão, PJ Oliveira, J Holy, CR Oliveira, KB Wallace Cancer chemotherapy and pharmacology 64, 811-827, 2009 | 116 | 2009 |
Vital imaging of H9c2 myoblasts exposed to tert-butylhydroperoxide – characterization of morphological features of cell death VA Sardão, PJ Oliveira, J Holy, CR Oliveira, KB Wallace BMC Cell Biology 8, 1-15, 2007 | 84 | 2007 |
Metabolic remodeling during H9c2 myoblast differentiation: relevance for in vitro toxicity studies SL Pereira, J Ramalho-Santos, AF Branco, VA Sardao, PJ Oliveira, ... Cardiovascular toxicology 11, 180-190, 2011 | 82 | 2011 |
The mitochondrial permeability transition pore: an evolving concept critical for cell life and death G Morciano, N Naumova, P Koprowski, S Valente, VA Sardão, Y Potes, ... Biological Reviews 96 (6), 2489-2521, 2021 | 81 | 2021 |
Isoproterenol cytotoxicity is dependent on the differentiation state of the cardiomyoblast H9c2 cell line AF Branco, SL Pereira, AC Moreira, J Holy, VA Sardão, PJ Oliveira Cardiovascular toxicology 11, 191-203, 2011 | 72 | 2011 |
Estrogens decrease osteoclast number by attenuating mitochondria oxidative phosphorylation and ATP production in early osteoclast precursors HN Kim, F Ponte, I Nookaew, S Ucer Ozgurel, A Marques-Carvalho, S Iyer, ... Scientific reports 10 (1), 11933, 2020 | 69 | 2020 |
Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts AF Branco, SF Sampaio, AC Moreira, J Holy, KB Wallace, I Baldeiras, ... Cardiovascular toxicology 12, 326-340, 2012 | 66 | 2012 |
Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells—Nuclear vs. mitochondrial effects TL Serafim, JAC Matos, VA Sardao, GC Pereira, AF Branco, SL Pereira, ... biochemical pharmacology 76 (11), 1459-1475, 2008 | 66 | 2008 |
Mitochondrial apoptosis-inducing factor is involved in doxorubicin-induced toxicity on H9c2 cardiomyoblasts. S Moreira, Branco, Sampaio, Cunha-Oliveira, Martins, Holy, Oliveira Biochim Biophys Acta 1842 (12 Pt A), 2468-78, 2014 | 63* | 2014 |
Mitochondrial apoptosis-inducing factor is involved in doxorubicin-induced toxicity on H9c2 cardiomyoblasts. S Moreira, Branco, Sampaio, Cunha-Oliveira, Martins, Holy, Oliveira Biochim Biophys Acta 1842 (12 Pt A), 2468-78, 2014 | 63* | 2014 |